[논문]Regulation and status of herbal medicine clinical trials in Korea: a narrative review

Lee, Boram; Choi, Yujin; Kim, Pyung-Wha; Yang, Changsop; Lee, Myeong Soo

doi:10.1016/j.imr.2020.100688

[해외논문] Regulation and status of herbal medicine clinical trials in Korea: a narrative review 원문보기

Integrative medicine research, v.10 no.2, 2021년, pp.100688 -

Lee, Boram (Clinical Medicine Division, Korea Institute of Oriental Medicine, Daejeon, Republic of Korea) , Choi, Yujin , Kim, Pyung-Wha , Yang, Changsop , Lee, Myeong Soo

Abstract ▼ AI-Helper

BackgroundHerbal medicine has been used frequently in Korean medicine. We aimed to summarize the relevant regulations for herbal medicine clinical trials and to analyze their current status in the Republic of Korea.MethodsWe searched for legislation to find regulations on herbal medicine clinical trials. Additionally, the websites of the Korean Ministry of Food and Drug Safety (KMFDS) and Clinical Research Information Service (CRIS) were searched to investigate the current status of them.ResultsTo conduct herbal medicine clinical trials for new drugs or previously approved drugs outside of indications, investigational new drug (IND) approval should be obtained from the KMFDS. For clinical trials of herbal medicines that have been used for more than 3 years with 200 cases at the clinical trial institution, nonclinical data can be exempted from IND approval. Total 95 and 108 herbal medicine clinical trials from the KMFDS and CRIS websites were analyzed. The number of clinical trials showed an increasing trend each year, as did KMFDS-regulated clinical trials. Recently, three clinical trials targeting new herbal formulations frequently used in Korean medicine institutions have been approved based on relevant regulations.ConclusionWe confirmed that herbal medicine clinical trials are managed through strict regulations, which can ensure the safe and effective use of herbal medicine. Despite strict regulations, attempts to accumulate evidence through clinical trials for herbal medicine are increasing. High-quality clinical trials should be conducted to develop new drugs that reflect the clinical setting using relevant regulations, evaluate the efficacy and safety of the drugs, and strengthen insurance coverage.

Keyword

참고문헌 (21)

1 Lee Y.M. Introduction to evidence based medicine Korean J Vasc Endovasc Surg 19 2 2003 212 219
2 Guideline for Approving Clinical Study Plans on Drugs. MFDS Notification No. 2019-146. December 30, 2019. http://www.law.go.kr/admRulLsInfoP.do?admRulSeq=2100000185510. Accessed September 10, 2020.
3 National Institute of Food and Drug Safety Evaluation Global drug development and evaluation trends 2012 National Institute of Food and Drug Safety Evaluation Cheongju, Korea
4 Regulation on Safety of Medicinal Products, etc. Ordinance of the Prime Minister No. 1641. September 7, 2020. http://www.law.go.kr/lsInfoP.do?lsiSeq=221475&efYd=20200907&ancYnChk=0#0000. Accessed September 10, 2020.
5 Regulation on Approval and Notification of Herbal (crude) Medicinal Preparations, Etc. MFDS Notification No. 2019-143. December 30, 2019. http://www.law.go.kr/admRulLsInfoP.do?chrClsCd=&admRulSeq=2100000185655. Accessed September 10, 2020.
6 2010 Korea Research-based Pharmaceutical Industry Association KOREA IND booklet 2011 Korea Research-based Pharmaceutical Industry Association Seoul, Korea
7 Dai L. Cheng C.W. Tian R. Standard Protocol Items for Clinical Trials with Traditional Chinese Medicine 2018: Recommendations, Explanation and Elaboration (SPIRIT-TCM Extension 2018) Chin J Integr Med 25 1 2019 71 79 30484022
8 Cheng C.W. Wu T.X. Shang H.C. CONSORT extension for chinese herbal medicine formulas 2017: Recommendations, explanation, and elaboration Ann Intern Med 167 2 2017 112 121 28654980

상세보기
9 National Institute of Food and Drug Safety Evaluation Complementary casebook of investigational new drug application 2019 National Institute of Food and Drug Safety Evaluation Cheongju, Korea
10 US Food Drug Administration Guidance for industry: Estimating the maximum safe starting dose in adult healthy volunteer 2005 Rockville, MD US Food and Drug Administration
11 Guideline center for Korean Medicine IND approval Casebook for the Investigator’s Clinical Trials - focusing on herbal medicine used for more than 3 years / 200 cases - 2019 Korean Studies Information Co., Ltd. Gyeonggi-do
12 Woo H.L. Ji H.R. Kim S. Efficacy and safety of herbal medicine (Dangguijagyag-san) for primary dysmenorrhea: study protocol for a randomized, double-blind, placebo-controlled, parallel-group, multi-center trial Integr Med Res 9 2 2020 100394
13 Joo Y.J. Kim J.C. Lee E.K. Survey on the korean medicine doctor’s awareness of the extension and activation of herbal medicine preparations insurance benefits Journal of Society of Preventive Korean Medicine 22 3 2018 31 44
14 Kim Y.J. Usage and consumption of Korean medicine Report in 2017 2018 National Institute for Korean Medicine Development Seoul, Korea
15 Kim H.J. Bae H.S. Park S.U. Moon S.K. Park J.M. Jung W.S. Clinical approach to the standardization of oriental medical diagnostic pattern identification in stroke patients Evid Based Complement Alternat Med 2011 2011

상세보기
16 Yeo M. Park K. Lee Y. A national-wide survey on utilization of pattern identification for chronic diseases among Korean medicine doctors Journal of Society of Preventive Korean Medicine 21 2 2017 23 34
17 Jin H.J. Lee J. Jang E. Research trends of pattern identification of korean medicine using the network analysis J Korea Contents Assoc 14 12 2014 1037 1046
18 Motoo Y. Arai I. Tsutani K. Use of Kampo diagnosis in randomized controlled trials of Kampo products in Japan: a systematic review PLoS One 9 8 2014 e104422

상세보기
19 Yeung W.F. Chung K.F. Ng K.Y. Yu YM Zhang S.P. Ng B.F. Prescription of chinese herbal medicine in Pattern-Based traditional chinese medicine treatment for depression: A systematic review Evid Based Complement Alternat Med 2015 2015 160189

상세보기
20 Witt C.M. Aickin M. Cherkin D. Effectiveness guidance document (EGD) for Chinese medicine trials: A consensus document Trials 15 2014 169 24885146

상세보기
21 Watanabe K. Matsuura K. Gao P. Traditional Japanese Kampo Medicine: Clinical Research between Modernity and Traditional Medicine-The State of Research and Methodological Suggestions for the Future Evid Based Complement Alternat Med 2011 2011 513842

상세보기

LOADING...

활용도 분석정보

상세보기

다운로드

내보내기

활용도 Top5 논문

해당 논문의 주제분야에서 활용도가 높은 상위 5개 콘텐츠를 보여줍니다.
더보기 버튼을 클릭하시면 더 많은 관련자료를 살펴볼 수 있습니다.

원문 보기

AccessON 원문보기

원문 URL 링크

DOI : 10.1016/j.imr.2020.100688 [무료]
PubMed Central : 저널 > 논문 [무료]
Elsevier : 저널
AccessON : 저널

*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.

오픈액세스(OA) 유형

GOLD

오픈액세스 학술지에 출판된 논문

저작권 관리 안내

내보내기 메뉴

내보내기 구분

파일저장
인쇄
메일전송

구성항목

기본정보
상세정보

관리번호, 논문명, 저널/프로시딩명, 저자 , 발행년, 권, 호, 시작페이지, 끝페이지, 발행기관

저장형식

Text(ASCII format)
Excel format
RefWorks Direct Export
RIS format (for Reference Manager, ProCite, EndNote), Scholar's Aids, Mendeley

메일정보

받는사람 (필수): @
보내는사람 (선택): @
제목
내용: KISTI 검색결과 이메일 서비스

안내

총 건의 자료가 검색되었습니다.

다운받으실 자료의 인덱스를 입력하세요. (1-10,000)

검색결과의 순서대로 최대 10,000건 까지 다운로드가 가능합니다.

데이타가 많을 경우 속도가 느려질 수 있습니다.(최대 2~3분 소요)

다운로드 파일은 UTF-8 형태로 저장됩니다.
파일의 내용이 제대로 보이지 않을실 때는 웹브라우저 상단의 보기 -> 인코딩 -> 자동선택 여부를 확인하십시오.

Text(ASCII format)
Excel format

표제어: PCR

동의어: Packet Collision Rate

용어 설명 출처 목록 (6)

용어 설명: PCR은 세균 특이성이 있는 primer를 이용하여 적은 수의 세균이 있을지라도 쉽게 검출할 수 있는 유용한 방법이며, 이를 이용하여 구강 내 치면세균막이나 타액에서 직접 세균을 검출할 수 있게 되었다[8].

AI-Helper ※ AI-Helper는 을 사용합니다.

AI-Helper

안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

연합인증